Company: FORA
Filing Date: 2025-12-04
Form Type: PRE 14A
Source: 0001140361-25-044359
Chunk: 10

Company: Forian Inc.
Filing Date: 2025-12-04
Form: PRE 14A
Chunk 10
---
 of the General Corporation Law of the State of Delaware (the “ DGCL ”) as the “ Redomiciliation ”. The Board recommends that the stockholders of the Company adopt the resolutions of the Board approving the Redomiciliation, included as Appendix A to this Proxy Statement, as more fully described in this Proposal 1 (the “ Redomiciliation Resolutions ”). This approval and recommendation has been approved by the Board, with directors Max Wygod, Adam Dublin and Shahir Kassam-Adams, each of whom is a member of the Consortium, not participating, acting upon the recommendation of the Special Committee. If stockholders approve the Redomiciliation, we will effect the Redomiciliation by converting from the Delaware Corporation into the Maryland Corporation as provided in the DGCL and the MGCL. Approval of this Proposal 1 will constitute the adoption of the Redomiciliation Resolutions.

### Background and Special Committee
The following chronology summarizes key meetings and events that led to the decision by the Board to approve the Redomiciliation and recommend it to the Company’s stockholders for approval. The following chronology does not purport to catalogue every communication among the Board, the Special Committee, the Consortium, management of the Company or the respective representatives of such parties.

The Board regularly reviews and evaluates the Company’s business and long-term strategy, competitive position, historical performance, future prospects and opportunities, with the goal of enhancing stockholder value. These reviews have included discussions as to the Company’s strategic alternatives, including continuing to execute on its strategy as a standalone company, pursuing acquisitions or pursuing a sale or business combination transaction.

Over the course of 2024, the Board engaged in a comprehensive evaluation of strategic alternatives and facilitated discussions with various counterparties, including Party A and Party B referenced below. Certain of such counterparties received preliminary confidential information regarding the Company and certain aspects of its financial and commercial profile from the Company. Such comprehensive evaluation of strategic alternatives ended in no indications of interest with respect to the Company.

On August 25, 2025, a consortium, led by Max Wygod, the Chief Executive Officer and Executive Chair of the Company (the “ Consortium ”), submitted a non-binding proposal to the Board to acquire all of the outstanding shares of Common Stock not currently owned by the Consortium, for $2.10 per share in cash (the “ Take-Private Offer ”).

Also on August 25, 2025, following receipt of the Take-Private Offer, the Board held a special meeting by videoconference with